These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 21541940)

  • 1. Feasibility of atomic force microscopy for determining crystal growth rates of nifedipine at the surface of amorphous solids with and without polymers.
    Miyazaki T; Aso Y; Kawanishi T
    J Pharm Sci; 2011 Oct; 100(10):4413-20. PubMed ID: 21541940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An investigation into the role of polymeric carriers on crystal growth within amorphous solid dispersion systems.
    Tian Y; Jones DS; Andrews GP
    Mol Pharm; 2015 Apr; 12(4):1180-92. PubMed ID: 25692314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Moisture-induced surface crystallization of spray-dried amorphous lactose particles studied by atomic force microscopy.
    Mahlin D; Berggren J; Alderborn G; Engström S
    J Pharm Sci; 2004 Jan; 93(1):29-37. PubMed ID: 14648633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization and stability of solid dispersions based on PEG/polymer blends.
    Bley H; Fussnegger B; Bodmeier R
    Int J Pharm; 2010 May; 390(2):165-73. PubMed ID: 20132875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystallization rate of amorphous nifedipine analogues unrelated to the glass transition temperature.
    Miyazaki T; Yoshioka S; Aso Y; Kawanishi T
    Int J Pharm; 2007 May; 336(1):191-5. PubMed ID: 17184940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solvent-mediated amorphous-to-crystalline transformation of nitrendipine in amorphous particle suspensions containing polymers.
    Xia D; Wu JX; Cui F; Qu H; Rades T; Rantanen J; Yang M
    Eur J Pharm Sci; 2012 Aug; 46(5):446-54. PubMed ID: 22484330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A method to evaluate the effect of contact with excipients on the surface crystallization of amorphous drugs.
    Zhang SW; Yu L; Huang J; Hussain MA; Derdour L; Qian F; de Villiers MM
    AAPS PharmSciTech; 2014 Dec; 15(6):1516-26. PubMed ID: 25037732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mobility-based estimation of the crystallization rates of amorphous nifedipine and phenobarbital in poly(vinylpyrrolidone) solid dispersions.
    Aso Y; Yoshioka S; Kojima S
    J Pharm Sci; 2004 Feb; 93(2):384-91. PubMed ID: 14705195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of polymers on the crystallization and phase transition kinetics of amorphous nifedipine during dissolution in aqueous media.
    Raina SA; Alonzo DE; Zhang GG; Gao Y; Taylor LS
    Mol Pharm; 2014 Oct; 11(10):3565-76. PubMed ID: 25185035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal growth formation in melt extrudates.
    Bruce C; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
    Int J Pharm; 2007 Aug; 341(1-2):162-72. PubMed ID: 17524578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanistic investigation of Pluronic based nano-crystalline drug-polymer solid dispersions.
    Qian F; Tao J; Desikan S; Hussain M; Smith RL
    Pharm Res; 2007 Aug; 24(8):1551-60. PubMed ID: 17380258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FTIR spectroscopic study of poly(ethylene glycol)-nifedipine dispersion stability in different relative humidities.
    Iqbal WS; Chan KL
    J Pharm Sci; 2015 Jan; 104(1):280-4. PubMed ID: 25410816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the microstructure of semicrystalline solid dispersions.
    Zhu Q; Taylor LS; Harris MT
    Mol Pharm; 2010 Aug; 7(4):1291-300. PubMed ID: 20550195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-time in situ X-ray micro-computed tomography study of the effect of impurities on the crystallization of amorphous nifedipine.
    Amano Y; Misawa T; Miyazaki T; Ando D; Koide T; Izutsu KI; Kanazawa H; Hanaoka K; Yamamoto E
    J Pharm Biomed Anal; 2023 Mar; 226():115248. PubMed ID: 36645986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surface-enhanced crystallization of amorphous nifedipine.
    Zhu L; Wong L; Yu L
    Mol Pharm; 2008; 5(6):921-6. PubMed ID: 19434917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Polymer Enrichment at the Crystal-Liquid Interface on Crystallization Kinetics of Amorphous Solid Dispersions.
    Zhang J; Shi Q; Tao J; Peng Y; Cai T
    Mol Pharm; 2019 Mar; 16(3):1385-1396. PubMed ID: 30716277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solid dispersion of spironolactone with porous silica prepared by the solvent method.
    Uchino T; Yasuno N; Yanagihara Y; Suzuki H
    Pharmazie; 2007 Aug; 62(8):599-603. PubMed ID: 17867555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disparities of Single-Particle Growth Rates in Buried Versus Exposed Ritonavir Crystals within Amorphous Solid Dispersions.
    Griffin SR; Takanti N; Sarkar S; Song Z; Vogt AD; Danzer GD; Simpson GJ
    Mol Pharm; 2020 Dec; 17(12):4564-4571. PubMed ID: 33151697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gelatin Nano-coating for Inhibiting Surface Crystallization of Amorphous Drugs.
    Teerakapibal R; Gui Y; Yu L
    Pharm Res; 2018 Jan; 35(1):23. PubMed ID: 29305725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solid dispersion of acetaminophen and poly(ethylene oxide) prepared by hot-melt mixing.
    Yang M; Wang P; Huang CY; Ku MS; Liu H; Gogos C
    Int J Pharm; 2010 Aug; 395(1-2):53-61. PubMed ID: 20435110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.